SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000912282-08-001614
Filing Date
2008-11-10
Accepted
2008-11-10 11:30:48
Documents
3
Period of Report
2008-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 oncogenex8k_110708.htm 8-K 18155
2 PRESS RELEASE Q3 FINANCIAL RESULTS ex99_1.htm EX-99.1 106437
3 GRAPHIC img1.jpg GRAPHIC 3348
  Complete submission text file 0000912282-08-001614.txt   130959
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21243 | Film No.: 081174051
SIC: 2835 In Vitro & In Vivo Diagnostic Substances